{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:54:20Z","timestamp":1787727260078,"version":"build-2784847793"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019K066"],"award-info":[{"award-number":["2019K066"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["DQCP20\/21PQ08"],"award-info":[{"award-number":["DQCP20\/21PQ08"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020T130561"],"award-info":[{"award-number":["2020T130561"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M661956"],"award-info":[{"award-number":["2019M661956"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900993"],"award-info":[{"award-number":["31900993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007062","name":"Yangzhou University","doi-asserted-by":"publisher","award":["5020\/137011461"],"award-info":[{"award-number":["5020\/137011461"]}],"id":[{"id":"10.13039\/501100007062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jconrel.2021.11.035","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T22:26:28Z","timestamp":1637879188000},"page":"314-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Erythrocyte-enabled immunomodulation for vaccine delivery"],"prefix":"10.1016","volume":"341","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongling","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.jconrel.2021.11.035_bb0005","first-page":"61","article-title":"Influenza virus: 100 years on, are we prepared against the next influenza pandemic?","volume":"16","author":"Medina","year":"1918","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0010","doi-asserted-by":"crossref","first-page":"eabd1525","DOI":"10.1126\/scitranslmed.abd1525","article-title":"Development and deployment of COVID-19 vaccines for those most vulnerable","volume":"13","author":"Koff","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0015","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0020","first-page":"140","article-title":"Vaccine immunotherapy for cancer","volume":"5","author":"Bridgewater","year":"1995","journal-title":"Mol. Cell Biol. Hum. Dis. Ser."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0025","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0030","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","article-title":"Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial","volume":"27","author":"Ribeiro","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41577-021-00504-3","article-title":"mRNA vaccine shows promise in autoimmunity","volume":"21","author":"Flemming","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2021.03.027","article-title":"Delivery of nanoparticle antigens to antigen-presenting cells: from extracellular specific targeting to intracellular responsive presentation","volume":"333","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","article-title":"State of the art in PEGylation: the great versatility achieved after forty years of research","volume":"161","author":"Pasut","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0060","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","article-title":"Revealing the immunogenic risk of polymers","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","volume":"106","author":"Villa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0075","doi-asserted-by":"crossref","first-page":"21495","DOI":"10.1073\/pnas.0907127106","article-title":"Red blood cell-mimicking synthetic biomaterial particles","volume":"106","author":"Doshi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0080","first-page":"958","article-title":"Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation","volume":"32","author":"Chambers","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/14712598.2012.661710","article-title":"Nanoparticles disguised as red blood cells to evade the immune system","volume":"12","author":"Fang","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.201700270","article-title":"Red blood cells for drug delivery","volume":"1","author":"Yan","year":"2017","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0095","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acs.bioconjchem.7b00758","article-title":"Red blood cells as smart delivery systems","volume":"29","author":"Han","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1517\/17425247.2014.927436","article-title":"Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies","volume":"11","author":"Bhateria","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/bp060333l","article-title":"Identification of peptide ligands facilitating nanoparticle attachment to erythrocytes","volume":"23","author":"Hall","year":"2007","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2016.05.008","article-title":"Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution","volume":"106","author":"Rossi","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2006.06.032","article-title":"Applications of carrier erythrocytes in delivery of biopharmaceuticals","volume":"118","author":"Hamidi","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0120","doi-asserted-by":"crossref","first-page":"eaaw6870","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood cell\u2013derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","volume":"5","author":"Han","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0125","doi-asserted-by":"crossref","first-page":"17727","DOI":"10.1073\/pnas.2002880117","article-title":"Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function","volume":"117","author":"Ukidve","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0130","doi-asserted-by":"crossref","first-page":"e1500112","DOI":"10.1126\/sciadv.1500112","article-title":"Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase","volume":"1","author":"Lorentz","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41551-020-00644-2","article-title":"Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases","volume":"5","author":"Zhao","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0140","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1073\/pnas.1216353110","article-title":"Engineering antigens for in situ erythrocyte binding induces T-cell deletion","volume":"110","author":"Kontos","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120826","article-title":"Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations","volume":"10","author":"Damgaard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12026-018-8988-5","article-title":"Phagocytosis and oxycytosis: two arms of human innate immunity","volume":"66","author":"Minasyan","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-065X.2011.01006.x","article-title":"Armed response: how dying cells influence T-cell functions","volume":"241","author":"Ferguson","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0165","doi-asserted-by":"crossref","first-page":"eabi6326","DOI":"10.1126\/sciadv.abi6326","article-title":"A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine","volume":"7","author":"Zhai","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0170","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1021\/acsnano.5b07716","article-title":"Different-sized gold nanoparticle activator\/antigen increases dendritic clls accumulation in liver-draining lymph nodes and CD8+ T cell responses","volume":"10","author":"Zhou","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0175","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1021\/acs.nanolett.8b01406","article-title":"Engineering dendritic cells-based vaccines and PD-1 blockade in self-assembled peptide nanofibrous hydrogel to amplify antitumor T-cell immunity","volume":"18","author":"Yang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0180","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/acs.nanolett.0c00893","article-title":"Programmable delivery of immune adjuvant to tumor-infiltrating dendritic cells for cancer immunotherapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119928","article-title":"Quantum dot-pulsed dendritic cell vaccines plus macrophage polarization for amplified cancer immunotherapy","volume":"242","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2017.02.010","article-title":"The cancer-immunity cycle as rational design for synthetic cancer drugs: novel DC vaccines and CAR T-cells","volume":"45","author":"Ramachandran","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0195","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1172\/JCI126199","article-title":"Endogenous T cells prevent tumor immune escape following adoptive T cell therapy","volume":"129","author":"Walsh","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0200","doi-asserted-by":"crossref","first-page":"eaaw4744","DOI":"10.1126\/scitranslmed.aaw4744","article-title":"Regulatory T cells engineered with TCR signaling\u2013responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter","volume":"12","author":"Eskandari","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aav8692","article-title":"Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor","volume":"365","author":"Ma","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0210","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ymthe.2017.08.010","article-title":"Combination cancer therapy using chimeric antigen receptor-engineered natural killer cells as drug carriers","volume":"25","author":"Siegler","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0215","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1002\/anie.202106730","article-title":"In vivo tracking of cell viability for adoptive natural kller cell-based immunotherapy by ratiometric NIR-II fluorescence imaging","volume":"60","author":"Liao","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0220","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1021\/acsnano.1c01889","article-title":"Magneto-activation and magnetic resonance imaging of natural killer cells labeled with magnetic nanocomplexes for the treatment of solid tumors","volume":"15","author":"Sim","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101280","article-title":"Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes","volume":"40","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0230","first-page":"13481","volume":"111","author":"Copp","year":"2014","journal-title":"Clearance of pathological antibodies using biomimetic nanoparticles"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0235","article-title":"How do red blood cells know when to die?","volume":"5","author":"Arias","year":"2017","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0240","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/bloodadvances.2017004671","article-title":"Human and murine splenic neutrophils are potent phagocytes of IgG-opsonized red blood cells","volume":"1","author":"Meinderts","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0245","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Zheleznyak","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004210","article-title":"Particle simulation of oxidation induced band 3 clustering in human erythrocytes","volume":"11","author":"Shimo","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0255","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/mp1001697","article-title":"Improving protein pharmacokinetics by engineering erythrocyte affinity","volume":"7","author":"Kontos","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0260","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1073\/pnas.1620843114","article-title":"Plasmodium falciparum erythrocyte-binding antigen 175 triggers a biophysical change in the red blood cell that facilitates invasion","volume":"114","author":"Koch","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000342171","article-title":"Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells","volume":"39","author":"Lutz","year":"2012","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0270","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bjh.14476","article-title":"Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study","volume":"176","author":"Hierso","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0275","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/jcmm.12778","article-title":"Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin","volume":"20","author":"Qadri","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRPot) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0285","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0290","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-14-2520","article-title":"Molecular pathways: activating T cells after cancer cell phagocytosis from blockade of CD47 \u201cDon\u2019t eat me\u201d signals","volume":"21","author":"McCracken","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002523","article-title":"Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy","volume":"9","author":"Shi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0300","first-page":"265","article-title":"Hemoglobin and erythrocyte count are independently and positively associated with arterial stiffness in a community-based study","volume":"35","author":"Sun","year":"2021","journal-title":"Hypertens."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0305","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","article-title":"Cell-based drug delivery","volume":"60","author":"Pierig\u00e8","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0310","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1083\/jcb.74.3.690","article-title":"Plasma membrane folds on the mast cell surface and their relationship to secretory activity","volume":"74","author":"Burwen","year":"1977","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0315","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days","volume":"116","author":"Pillay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0320","first-page":"96","article-title":"Fetal erythrocyte lifespan","volume":"15","author":"Harrison","year":"1979","journal-title":"Aust. Paediatr. J."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0325","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2016-03-700336","article-title":"Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives","volume":"127","author":"Beneytez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pathophys.2016.03.001","article-title":"Mechanisms and pathways for the clearance of bacteria from blood circulation in health and disease","volume":"23","author":"Minasyan","year":"2016","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1556\/EuJMI.4.2014.2.7","article-title":"Microbiology, immunology, erythrocyte and blood antibacterial defense","volume":"4","author":"Minasyan","year":"2014","journal-title":"Eur. J. Microbiol. Immunol. (Bp)."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0340","first-page":"1","article-title":"Erythrocyte: bacteria killer and bacteria pray, international","volume":"3","author":"Minasyan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0345","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/08830185.2014.956359","article-title":"Erythrocyte and leukocyte: two partners in bacteria killing","volume":"33","author":"Minasyan","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1556\/1886.2021.00008","article-title":"Oxycytosis and the role of triboelectricity and oxidation in bacteria clearing from the bloodstream","volume":"11","author":"Minasyan","year":"2021","journal-title":"Eur. J. Microbiol. Immunol. (Bp)."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0355","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcrc.2017.04.015","article-title":"Sepsis and septic shock: pathogenesis and treatment perspectives","volume":"40","author":"Minasyan","year":"2017","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0360","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ni1007-1029","article-title":"Oxidative burst without phagocytes: the role of respiratory proteins","volume":"8","author":"Bogdan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2004.08.005","article-title":"Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes","volume":"100","author":"Chambers","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0370","first-page":"9","article-title":"Of macrophages and red blood cells; a complex love story","volume":"5","author":"Back","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0375","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1159\/000335798","article-title":"Regulation of phosphatidylserine exposure in red blood cells","volume":"28","author":"Nguyen","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000087725","article-title":"Erythrocyte aging: a more than superficial resemblance to apoptosis?","volume":"16","author":"Bosman","year":"2005","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.cdd.4401144","article-title":"Cation channels trigger apoptotic death of erythrocytes","volume":"10","author":"Lang","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2012.12.044","article-title":"Red blood cells as innovative antigen carrier to induce specific immune tolerance","volume":"443","author":"Cremel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0395","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yexcr.2005.07.002","article-title":"A physiological model to study iron recycling in macrophages","volume":"310","author":"Delaby","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0400","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.cdd.4400946","article-title":"Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria","volume":"8","author":"Bratosin","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0405","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00926740","article-title":"Modulated red blood cell survival by membrane protein clustering","volume":"144","author":"Chiarantini","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0410","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1038\/s41598-018-27109-6","article-title":"Anti-band 3 and anti-spectrin antibodies are increased in plasmodium vivax infection and are associated with anemia","volume":"8","author":"Mour\u00e3o","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0415","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4049\/jimmunol.176.1.441","article-title":"Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation","volume":"176","author":"Ing","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0420","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/trf.15033","article-title":"Monoclonal anti-CD47 interference in red cell and platelet testing","volume":"59","author":"Velliquette","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0425","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.1999.01217.x","article-title":"Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia","volume":"104","author":"Cappellini","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0430","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1111\/trf.12755","article-title":"Macrophages clear refrigerator storage\u2013damaged red blood cells and subsequently secrete cytokines in vivo, but not in vitro, in a murine model","volume":"54","author":"Wojczyk","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0435","article-title":"Broad-spectrum neutralization of pore-forming toxins with human erythrocyte membrane-coated nanosponges","volume":"7","author":"Chen","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0440","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1021\/acsnano.9b02773","article-title":"Cell-membrane-cloaked oil nanosponges enable dual-modal detoxification","volume":"13","author":"Chen","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0445","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/acsnano.9b00661","article-title":"Ligand-modified cell membrane enables targeted delivery of drug nanocrystals to glioma","volume":"13","author":"Chai","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0450","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1021\/acs.nanolett.8b05051","article-title":"Biomimetic micromotor enables active delivery of antigens for oral vaccination","volume":"19","author":"Wei","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0455","doi-asserted-by":"crossref","first-page":"eaat0485","DOI":"10.1126\/scirobotics.aat0485","article-title":"Hybrid biomembrane\u2013functionalized nanorobots for concurrent removal of pathogenic bacteria and toxins","volume":"3","author":"\u00c1vila","year":"2018","journal-title":"Sci. Robot."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0465","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7150\/thno.14471","article-title":"Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors","volume":"6","author":"Luk","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0470","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.biomaterials.2019.01.020","article-title":"A new class of biological materials: cell membrane-derived hydrogel scaffolds","volume":"197","author":"Fan","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201803002","article-title":"Worm-like biomimetic nanoerythrocyte carrying siRNA for melanoma gene therapy","volume":"14","author":"Wang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0480","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biomaterials.2018.11.021","article-title":"Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors","volume":"192","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0485","doi-asserted-by":"crossref","first-page":"eabd3803","DOI":"10.1126\/sciadv.abd3803","article-title":"Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza a virus inhibitors","volume":"7","author":"Nie","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0490","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biomaterials.2018.11.021","article-title":"Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors","volume":"192","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0495","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1126\/science.1377404","article-title":"Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand","volume":"256","author":"Hahn","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0500","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1021\/acsnano.5b01042","article-title":"Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma","volume":"9","author":"Guo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0505","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/acsnano.8b07241","article-title":"Biomimetic glyconanoparticle vaccine for cancer immunotherapy","volume":"13","author":"Reuven","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0510","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/pharmaceutics11110612","article-title":"The role of nanovaccine in cross-presentation of antigen-presenting cells for the activation of CD8+ T cell responses","volume":"11","author":"Kim","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0515","doi-asserted-by":"crossref","first-page":"1701864","DOI":"10.1002\/smll.201701864","article-title":"Surface-engineering of red blood cells as artificial antigen presenting cells promising for cancer immunotherapy","volume":"13","author":"Sun","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0520","doi-asserted-by":"crossref","first-page":"14842","DOI":"10.1002\/anie.202003367","article-title":"DNA-edited ligand positioning on red blood cells to enable optimized T cell activation for adoptive immunotherapy","volume":"59","author":"Sun","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0525","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1021\/acs.nanolett.7b03734","article-title":"Biologically inspired design of nanoparticle artificial antigen-presenting cells for immunomodulation","volume":"17","author":"Hickey","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0530","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1021\/acsnano.7b04955","article-title":"Biomimetic magnetosomes as versatile artificial antigen-presenting cells to potentiate T-cell-based anticancer therapy","volume":"11","author":"Zhang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0535","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0540","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nnano.2017.47","article-title":"Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes","volume":"12","author":"Wibroe","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.07.043","article-title":"Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: synergy between physical, chemical and biological approaches","volume":"68","author":"Anselmo","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0550","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0555","doi-asserted-by":"crossref","first-page":"eaax9250","DOI":"10.1126\/sciadv.aax9250","article-title":"Erythrocyte leveraged chemotherapy (ELeCt): nanoparticle assembly on erythrocyte surface to combat lung metastasis","volume":"5","author":"Zhao","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0560","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0565","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.exger.2006.06.045","article-title":"Assessment of survival of aging erythrocyte in circulation and attendant changes in size and CD147 expression by a novel two step biotinylation method","volume":"41","author":"Khandelwal","year":"2006","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0570","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0575","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V65.5.1056.1056","article-title":"Drug-induced endocytosis of neonatal erythrocytes","volume":"65","author":"Matovcik","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0580","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18433\/J37W2V","article-title":"Co-encapsulation of a drug with a protein in erythrocytes for improved drug loading and release: phenytoin and bovine serum albumin (BSA)","volume":"14","author":"Hamidi","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0585","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0024-3205(01)00991-2","article-title":"Mouse erythrocytes as carriers for coencapsulated alcohol and aldehyde dehydrogenase obtained by electroporation in vivo survival rate in circulation, organ distribution and ethanol degradation","volume":"68","author":"Lizano","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0590","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2013.12.019","article-title":"Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application","volume":"176","author":"He","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0595","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1537-2995.1999.39299154730.x","article-title":"Biotinylation modifies red cell antigens","volume":"39","author":"Cowley","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0600","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1470-8744.1996.tb00386.x","article-title":"Attachment of antibody to biotinylated red blood cells: immuno-red blood cells display high affinity to immobilized antigen and normal biodistribution in rats","volume":"24","author":"Muzykantov","year":"1996","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0605","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41467-017-00448-0","article-title":"Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0610","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0615","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.1409861111","article-title":"Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes","volume":"111","author":"Shi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0620","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41467-021-22898-3","article-title":"Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0625","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.1701746114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0630","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0635","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0640","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00043426-200404000-00002","article-title":"Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: children's cancer group study CCG-1961","volume":"26","author":"Panosyan","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0645","first-page":"299","article-title":"Immunogenicity of native or pegylated E. coli and Erwinia Asparaginases assessed by ELISA and surface plasmon resonance (SPR-Biacore) assays of IgG antibodies (Ab) in sera from patients with acute lymphoblastic Leukemia (ALL)","volume":"29","author":"Avramis","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0650","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U","article-title":"Toxicity of E. coli L-asparaginase in man","volume":"25","author":"Oettgen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0655","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.cdd.4400905","article-title":"Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis","volume":"8","author":"Berg","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0660","doi-asserted-by":"crossref","first-page":"17359","DOI":"10.1039\/D1NR04057J","article-title":"viaA numerical study on drug delivery multiscale synergy of cellular hitchhiking onto red blood cells","volume":"13","author":"Nikfar","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0665","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","article-title":"Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles","volume":"190","author":"Anselmo","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0670","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/acschembio.1c00216","article-title":"Asparaginyl ligase-catalyzed one-step cell surface modification of red blood cells","volume":"16","author":"Harmand","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003492","article-title":"Engineering of living cells with polyphenol-functionalized biologically active nanocomplexes","volume":"32","author":"Zhao","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.11.035_bb0680","article-title":"The effect of polymeric nanoparticles on biocompatibility of carrier red blood cells","volume":"11","author":"Pan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.11.035_bb0685","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41598-018-19897-8","article-title":"Nanoparticle properties modulate their attachment and effect on carrier red blood cells","volume":"8","author":"Pan","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:41:16Z","timestamp":1777509676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921006301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":137,"alternative-id":["S0168365921006301"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.035","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythrocyte-enabled immunomodulation for vaccine delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}